bayer-claim.com Open in urlscan Pro
85.214.112.147  Public Scan

Form analysis
1 forms found in the DOM

GET https://bayer-claim.com/

<form method="get" id="searchform" action="https://bayer-claim.com/">
  <i class="icon_search icon-search-fine"></i>
  <a href="#" class="icon_close"><i class="icon-cancel-fine"></i></a>
  <input type="text" class="field" name="s" placeholder="Enter your search">
  <input type="submit" class="display-none" value="">
</form>

Text Content

 * HOME
 * CONTACT




BAYER AG —
Loss Recovery Action
for Investors







TILP INFORMS –
KEY FACTS AT A GLANCE:

WHICH SECURITIES ARE AFFECTED?

The securities affected are initially Bayer AG shares: This also includes shares
acquired by take up of rights from a capital increase of Bayer AG. In addition,
claims also exist for shares resulting from mandatory convertible bonds issued
by Bayer AG and for derivatives on Bayer AG shares.

--------------------------------------------------------------------------------

WHAT IS THE RELEVANT PERIOD FOR CLAIMING LOSSES?

Purchase from 14.09.2016 until 19.03.2019 (respectively included).

DO THE CLAIMS FOR COMPENSATION ASSUME THAT THE SHARES WERE STILL HELD ON
19.03.2019?

No. The only decisive factor for claiming damages is that the securities were
purchased from September 14, 2016 until March 19, 2019.

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------


BACKGROUND TO THE INVESTOR LAWSUITS AGAINST BAYER AG

On July 10, 2020, TILP filed the first action for damages (“pilot action”)
pending before the Regional Court of Cologne on behalf of a British investor
against Bayer AG (hereinafter also "Bayer"). The subject matter of the lawsuit
is the events surrounding Bayer's acquisition of the U.S. agricultural and
chemical group Monsanto Company (hereinafter also "Monsanto") and its improper
capital market information. With its pilot action, TILP is seeking model case
proceedings under the German Capital Markets Model Case Act ("KapMuG").

With an unprecedented purchase price of approximately US $63 billion, the
Monsanto acquisition, announced on May 23, 2016 and completed by mid-2018,
represents the largest corporate acquisition in German economic history to date.

The acquisition was absorbed ambivalently by the public. While proponents
focused in particular on the economic advantages of the acquisition predicted by
Bayer, other observers viewed the takeover critically and saw considerable risks
for the Bayer Group.



The critics of the acquisition were ultimately to be proven right: When it
became publicly on Aug. 10, 2018, that Monsanto had been ruled to pay $289
million in damages by a California court in connection with the glyphosate-based
herbicide "Roundup," Bayer's stock plunged rapidly. More than €10 billion in
market capitalization was wiped out in the first few hours after the verdict
became known.

When the capital-markets also became aware in August 2018 that Monsanto, or
Bayer AG as its legal successor, is facing more than 8,000 additional, similar
lawsuits in the United States, the share price plunged further. At its peak,
Bayer shares lost more than 50 percent of their value during the legally
relevant claims period. In total, more than 30 billion euros in market
capitalization was thus wiped out in connection with the disclosure of the
actual risks of the acquisition. Currently, the stock market value of the Bayer
Group is between EUR 50 billion and EUR 60 billion, which is lower than the
purchase price paid for the acquisition of the Monsanto Group.

As of April 14, 2020, Monsanto had been served with lawsuits from about 48,600
plaintiffs in the U.S., according to official Bayer data. However, the total
number of lawsuits was far higher. Thus, on June 24, 2020, Bayer announced that
it had reached a series of agreements to substantially settle Monsanto's
relevant litigation in the United States. Bayer put the total of all lawsuits
filed and not (yet) filed at approximately 125,000, and in this context Bayer
agreed to pay up to $10.9 billion to settle the cases already pending and
possible future cases. By early November 2020, Bayer had reached a settlement
agreement for approximately 88,500 lawsuits. However, a separate agreement to
address and settle potential future lawsuits is still pending.

On January 7, 2021 Bayer finally announced that it had raised four billion euros
by issuing a bond. According to Bayer, the proceeds will be used for general
corporate purposes, including the refinancing of existing liabilities. According
to media reports, the income will also be used to finance the legal risks
assumed by Monsanto.


WHAT DOES THIS MEAN FOR YOU AS AN INVESTOR?

For the affected investors, the events described in connection with the Monsanto
acquisition imply substantial losses in the high double-digit billion range.
After the actual risks of the takeover became known, around 55% of the
shareholders present at the Annual Stockholders' Meeting of Bayer AG on April
26, 2019 voted against approving the actions of the Board of Management and thus
withdrew their confidence in the Board of Management for 2018 - a unique event
in the history of the DAX.

The investors represented by TILP accuse Bayer in particular of having informed
the capital market incorrectly and not in a timely manner about the actual risks
of the takeover. It is alleged that Bayer was informed of the numerous risks at
an early stage in the Monsanto takeover proceedings, but failed to communicate
these risks to the capital market as required by law, in particular in order not
to endanger the planned takeover and the capital measures required in this
connection. In particular, Bayer should have provided information about the
reasonable likelihood that U.S. courts could conclude in Jury-trials that
Roundup is carcinogenic.

Bayer itself states that it did not have full insight into the Monsanto Group's
books until August 2018 due to antitrust requirements, so that the risks arising
from the U.S. glyphosate damages lawsuits, among others, could not have been
assessed.

According to TILP`s firm legal opinion, even if this were to be assumed to be
true, Bayer should have informed the capital market that it was not possible for
Bayer to adequately assess the financial risk for Bayer resulting from the
takeover and to take appropriate precautionary measures due to its lack of
knowledge of all valuation bases in the course of the legal due diligence.

Also the fact that Bayer has already commissioned several expert opinions to
prove that the Bayer Board of Management acted dutifully in its relationship
with the company in connection with the Monsanto acquisition does not preclude
Bayer's liability to investors under capital market law. The question of whether
the capital market should have been informed comprehensively about the existing
risks of the takeover is completely independent of the question of whether the
Bayer-Board has fulfilled its internal obligations to the company.

Investors who purchased Bayer shares, mandatory convertible bonds on these
shares or derivatives on Bayer shares during the legally relevant damage period
from September 14, 2016 until March 19, 2019 are, in TILP`s firm legal opinion,
entitled to claim damages against Bayer AG due to the omitted or incorrect
capital market information.


YOUR CONTACTS AT TILP:


+49.7121.90909.38
BAYER-KLAGE@TILP.DE

--------------------------------------------------------------------------------

MARC SCHIEFER,
LL.M. (MIAMI)

--------------------------------------------------------------------------------



--------------------------------------------------------------------------------

GESCHÄFTSFÜHRER | RECHTSANWALT | BANKKAUFMANN ATTORNEY AT LAW NY | FACHANWALT
FÜR BANK- UND KAPITALMARKTRECHT

--------------------------------------------------------------------------------



--------------------------------------------------------------------------------



--------------------------------------------------------------------------------

CHRISTIAN HERRMANN

--------------------------------------------------------------------------------



--------------------------------------------------------------------------------

RECHTSANWALT

--------------------------------------------------------------------------------



--------------------------------------------------------------------------------



--------------------------------------------------------------------------------

MARVIN KEWE

--------------------------------------------------------------------------------



--------------------------------------------------------------------------------

GESCHÄFTSFÜHRER | RECHTSANWALT | BANKKAUFMANN
FACHANWALT FÜR BANK- UND KAPITALMARKTRECHT

--------------------------------------------------------------------------------



--------------------------------------------------------------------------------



--------------------------------------------------------------------------------

AXEL WEGNER

--------------------------------------------------------------------------------



--------------------------------------------------------------------------------

RECHTSANWALT

--------------------------------------------------------------------------------



--------------------------------------------------------------------------------



--------------------------------------------------------------------------------




TILP Rechtsanwaltsgesellschaft mbH
Einhornstraße 21
72138 Kirchentellinsfurt

Telefon: +49.7121.90909.85
Telefax: +49.7121.90909.81

E-Mail: bayer-klage@tilp.de
Internet: www.tilp.de

Legal Notice | Impressum
Privacy Notice | Datenschutz
TILP Rechtsanwälte | 2021


Datenschutzeinstellungen

Wir nutzen Cookies auf unserer Website. Die Verwendung von Cookies können Sie
grundsätzlich in Ihrem Browser steuern und gespeicherte Cookies dort jederzeit
selbst löschen. Sie können aber auch unter „individuelle
Datenschutzeinstellungen“ eine Einstellung zu den von unserer Webseite genutzten
Cookies vornehmen. Durch die weitere uneingeschränkte Nutzung dieser Website
stimmen Sie zunächst der Verwendung sämtlicher Cookies zu. Details zu den
jeweiligen Cookies und den Cookie-Kategorien finden Sie unter „Cookie-Details“
sowie in unserer „Datenschutzerklärung“. Wenn Sie unter 16 Jahre alt sind und
Ihre Zustimmung zu freiwilligen Diensten geben möchten, müssen Sie Ihre
Erziehungsberechtigten um Erlaubnis bitten. Wir verwenden Cookies und andere
Technologien auf unserer Website. Einige von ihnen sind essenziell, während
andere uns helfen, diese Website und Ihre Erfahrung zu verbessern.
Personenbezogene Daten können verarbeitet werden (z. B. IP-Adressen), z. B. für
personalisierte Anzeigen und Inhalte oder Anzeigen- und Inhaltsmessung. Weitere
Informationen über die Verwendung Ihrer Daten finden Sie in unserer
Datenschutzerklärung. Sie können Ihre Auswahl jederzeit unter Einstellungen
widerrufen oder anpassen.

Datenschutzeinstellungen
 * Essenziell
 * Externe Medien

Alle akzeptieren

Speichern

Nur essenzielle Cookies akzeptieren

Individuelle Datenschutzeinstellungen

Cookie-Details Datenschutzerklärung Impressum

Datenschutzeinstellungen

Wenn Sie unter 16 Jahre alt sind und Ihre Zustimmung zu freiwilligen Diensten
geben möchten, müssen Sie Ihre Erziehungsberechtigten um Erlaubnis bitten. Wir
verwenden Cookies und andere Technologien auf unserer Website. Einige von ihnen
sind essenziell, während andere uns helfen, diese Website und Ihre Erfahrung zu
verbessern. Personenbezogene Daten können verarbeitet werden (z. B.
IP-Adressen), z. B. für personalisierte Anzeigen und Inhalte oder Anzeigen- und
Inhaltsmessung. Weitere Informationen über die Verwendung Ihrer Daten finden Sie
in unserer Datenschutzerklärung. Hier finden Sie eine Übersicht über alle
verwendeten Cookies. Sie können Ihre Einwilligung zu ganzen Kategorien geben
oder sich weitere Informationen anzeigen lassen und so nur bestimmte Cookies
auswählen.

Alle akzeptieren Speichern Nur essenzielle Cookies akzeptieren

Zurück

Datenschutzeinstellungen
Essenziell (1)


Essenzielle Cookies ermöglichen grundlegende Funktionen und sind für die
einwandfreie Funktion der Website erforderlich.

Cookie-Informationen anzeigen Cookie-Informationen ausblenden

Name Borlabs Cookie Anbieter Eigentümer dieser Website, Impressum Zweck
Speichert die Einstellungen der Besucher, die in der Cookie Box von Borlabs
Cookie ausgewählt wurden. Cookie Name borlabs-cookie Cookie Laufzeit 1 Jahr

Externe Medien (4)
Externe Medien

Inhalte von Videoplattformen und Social-Media-Plattformen werden standardmäßig
blockiert. Wenn Cookies von externen Medien akzeptiert werden, bedarf der
Zugriff auf diese Inhalte keiner manuellen Einwilligung mehr.

Cookie-Informationen anzeigen Cookie-Informationen ausblenden

Akzeptieren Google Maps Name Google Maps Anbieter Google Ireland Limited, Gordon
House, Barrow Street, Dublin 4, Ireland Zweck Wird zum Entsperren von Google
Maps-Inhalten verwendet. Datenschutzerklärung
https://policies.google.com/privacy Host(s) .google.com Cookie Name NID Cookie
Laufzeit 6 Monate

Akzeptieren Twitter Name Twitter Anbieter Twitter International Company, One
Cumberland Place, Fenian Street, Dublin 2, D02 AX07, Ireland Zweck Wird
verwendet, um Twitter-Inhalte zu entsperren. Datenschutzerklärung
https://twitter.com/privacy Host(s) .twimg.com, .twitter.com Cookie Name
__widgetsettings, local_storage_support_test Cookie Laufzeit Unbegrenzt

Akzeptieren Vimeo Name Vimeo Anbieter Vimeo Inc., 555 West 18th Street, New
York, New York 10011, USA Zweck Wird verwendet, um Vimeo-Inhalte zu entsperren.
Datenschutzerklärung https://vimeo.com/privacy Host(s) player.vimeo.com Cookie
Name vuid Cookie Laufzeit 2 Jahre

Akzeptieren YouTube Name YouTube Anbieter Google Ireland Limited, Gordon House,
Barrow Street, Dublin 4, Ireland Zweck Wird verwendet, um YouTube-Inhalte zu
entsperren. Datenschutzerklärung https://policies.google.com/privacy Host(s)
google.com Cookie Name NID Cookie Laufzeit 6 Monate

powered by Borlabs Cookie

Datenschutzerklärung Impressum